A 6 month old child is suffering from patent ductus arteriosus (PDA) with congestive cardiac failure. Ligation of ductus arteriosus was decided for surgical management. The most appropriate inhalational anaesthetic agent of choice with minimal haemodynamic alteration for induction of anaesthesia is –

Okay, let's tackle this question about the appropriate inhalational anesthetic for a 6-month-old with PDA undergoing ligation. The user wants a detailed explanation following specific sections. First, I need to recall the core concept here. The question is about choosing an inhalational anesthetic with minimal hemodynamic effects. Since the patient has PDA and heart failure, maintaining stable hemodynamics is crucial.

The core concept would involve understanding which anesthetics don't cause significant changes in heart rate, blood pressure, or cardiac output. For infants with PDA, especially those with heart failure, we want to avoid agents that could cause hypotension or increase afterload, which might worsen the condition.

Now, the correct answer is likely sevoflurane. Sevoflurane is known for having minimal cardiovascular depression compared to other inhalational agents. It's often preferred in pediatric cases because it's less irritating and allows for smooth induction.

Why the other options are wrong: Let's assume the options include agents like halothane, isoflurane, desflurane, or nitrous oxide. Halothane can cause myocardial depression and decrease systemic vascular resistance, which is bad for a PDA patient. Isoflurane also causes vasodilation, which might not be ideal. Desflurane can cause airway irritation and increase heart rate, leading to instability. Nitrous oxide, while not as bad, doesn't provide the same smooth induction and might cause some hemodynamic changes due to its effects on oxygenation.

Clinical pearl: Sevoflurane is the go-to for pediatric anesthesia in cases where hemodynamic stability is critical. Remember that agents causing significant hypotension or increasing afterload should be avoided in PDA patients to prevent worsening of left-to-right shunt or increasing pulmonary hypertension.

Putting it all together, the correct answer is sevoflurane. Need to make sure the explanation is concise, covers all sections, and stays within the character limit.

**Core Concept**
Patent ductus arteriosus (PDA) creates a left-to-right shunt, increasing pulmonary blood flow. Hemodynamic stability is critical during anesthesia to avoid worsening cardiac failure or increasing pulmonary hypertension. Inhalational agents must minimize myocardial depression, systemic vascular resistance (SVR), and heart rate changes.

**Why the Correct Answer is Right**
**Sevoflurane** is the preferred agent due to its minimal cardiovascular depression. It maintains SVR and avoids significant myocardial depression, reducing the risk of left ventricular overload in PDA patients. It induces anesthesia rapidly with minimal airway irritation, ideal for pediatric cases. Unlike other agents, sevoflurane does not exacerbate shunting by preserving systemic vascular tone.

**Why Each Wrong Option is Incorrect**
**Option A: Halothane** causes marked myocardial depression and decreases SVR, worsening left-to-right shunting and cardiac output in PDA.
**Option B: Isoflurane** significantly reduces SVR and coronary steal, increasing pulmonary blood flow and risking pulmonary edema in heart failure.
**Option C: Desflurane** induces airway irritation and tachycardia, destabilizing hemodynamics in fragile cardiac patients.
**Option D: Nitrous oxide** decreases SVR and may cause hypoxia in PDA by reducing

✓ Correct Answer: A. Sevoflurane